Hikma Pharmaceuticals (HKMPY) Stock Chart & Stock Price History $51.68 -1.58 (-2.97%) As of 08/1/2025 01:34 PM Eastern Add Compare Share Share Chart Stock AnalysisChartDividendHeadlinesShort InterestBuy This Stock Hikma Pharmaceuticals Stock Price Performance The Hikma Pharmaceuticals (HKMPY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 5.90%, with a year-to-date return of 3.34%. In the past month, the stock has decreased 6.56%, reflecting recent market activity. As of the latest close, Hikma Pharmaceuticals traded at $51.68 with a market cap of and volume of 411 shares. Five years ago, the stock traded at $56.71, representing a 8.87% decrease over that period. At the time, it had a market cap of and a volume of 0 shares. Receive HKMPY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.49%1 Month Performance-6.56%3 Month Performance-3.95%Year-To-Date Performance+3.34%1 Year Performance+5.90%5 Year PerformanceN/A HKMPY Stock Chart for Saturday, August, 2, 2025 HKMPY Chart by TradingView Hikma Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$53.26$51.68-2.97%$51.68$51.68411 shs$0.0007/31/2025$53.26$53.26$53.26$53.26389 shs$0.0007/30/2025$54.11$53.26-1.57%$53.26$53.26389 shs$0.0007/29/2025$54.11$54.11$54.40$52.96548 shs$0.0007/28/2025$55.00$54.11-1.62%$54.40$52.96548 shs$0.0007/25/2025$55.00$55.00$55.33$55.00532 shs$0.0007/24/2025$55.00$55.00$55.33$55.00532 shs$0.0007/23/2025$53.99$55.00+1.87%$55.33$55.00532 shs$0.0007/22/2025$53.65$53.99+0.63%$53.99$53.99210 shs$0.0007/21/2025$53.71$53.65-0.11%$53.65$53.65397 shs$0.00 Get the Latest News and Ratings for HKMPY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$53.14$53.71+1.07%$53.71$53.71366 shs$0.0007/17/2025$53.14$53.14$53.14$53.14384 shs$0.0007/16/2025$54.41$53.14-2.34%$53.14$53.14384 shs$0.0007/15/2025$54.41$54.41$54.41$54.41229 shs$0.0007/14/2025$54.41$54.41$54.41$54.41229 shs$0.0007/11/2025$53.40$54.41+1.90%$54.41$54.41229 shs$0.0007/10/2025$53.40$53.40$53.40$53.40288 shs$0.0007/09/2025$55.09$53.40-3.06%$53.40$53.40288 shs$0.0007/08/2025$55.09$55.09$55.09$55.09572 shs$0.0007/07/2025$54.46$55.09+1.16%$55.09$55.09572 shs$0.0007/04/2025$54.46$54.46$54.46$54.46678 shs$0.0007/03/2025$55.31$54.46-1.54%$54.46$54.46678 shs$0.0007/02/2025$55.53$55.31-0.40%$55.31$55.31179 shs$0.0007/01/2025$55.53$55.53$55.53$55.53197 shs$0.00 Related Companies TGIFF Stock Chart CATV Stock Chart FFNTF Stock Chart ABSCF Stock Chart ATTBF Stock Chart ALEAF Stock Chart LBTSF Stock Chart ALVOW Stock Chart AZFL Stock Chart ERBB Stock Chart Receive HKMPY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:HKMPY) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
